| mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.028 |
0.9 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.034 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |